Medicare Enrolled

Dr. Michael Avakian, DPM

Podiatrist · Pasadena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2544 E WASHINGTON BLVD, Pasadena, CA 91107
6263984069
In practice since 2006 (19 years)
NPI: 1154335040 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Avakian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Avakian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Avakian

Dr. Michael Avakian is a podiatrist in Pasadena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Avakian performed 1,226 Medicare services across 756 unique beneficiaries.

Between the years covered by Open Payments, Dr. Avakian received a total of $2,022 from 26 pharmaceutical and/or device companies across 64 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in podiatrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Avakian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,226 Medicare services $2,022 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,226
Medicare services
Bottom 47% in CA for podiatrist
756
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~65 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
733 $76 $150
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
119 $95 $150
Toenail/fingernail removal, 1-5 nails
This procedure involves the removal of one to five fingernails or toenails.
111 $29 $100
Removal of thickened skin growths, 2-4
This procedure involves the removal of two to four benign, thickened skin growths. It is a minor surgical intervention to eliminate non-cancerous skin lesions.
82 $73 $175
Removal of noncancer thickened skin growth, 1 growth
This procedure involves the removal of a single benign, thickened skin growth. It is a minor surgical intervention to eliminate the lesion.
72 $60 $110
Removal of inflamed or infected skin, up to 10% of body surface
This procedure involves the surgical removal of skin affected by inflammation or infection. It is performed when the affected area covers up to 10 percent of the patient's total body surface area.
44 $49 $100
Wound tissue removal, 20 sq cm or less
This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less.
27 $78 $100
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
24 $78 $125
Simple separation of fingernail or toenail from nail bed, first nail
A procedure to separate the first fingernail or toenail from the underlying nail bed.
14 $90 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,022
Total received (2018-2024)
Avg $289/year across 7 years
Top 31% in CA for podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
64
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,022 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$355
2023
$316
2022
$355
2021
$286
2020
$33
2019
$272
2018
$404

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$136
Exact Sciences Corporation
$34
GlaxoSmithKline, LLC.
$32
Nevro Corp.
$29
Bayer Healthcare Pharmaceuticals Inc.
$23
Organogenesis Inc.
$23
Boston Scientific Corporation
$22
Smith+Nephew, Inc.
$22
Almatica Pharma LLC
$18
Ultragenyx Pharmaceutical Inc.
$17
Top 3 companies account for 56.6% of 2024 payments
All-time payments by company (2018-2024) ›
Organogenesis Inc.
$345
Abbott Laboratories
$263
GlaxoSmithKline, LLC.
$254
Bioventus LLC
$155
Cardiovascular Systems Inc.
$147
Lilly USA, LLC
$136
Smith+Nephew, Inc.
$93
Bausch Health US, LLC
$74
Kowa Pharmaceuticals America, Inc.
$66
Novo Nordisk Inc
$64
Almatica Pharma LLC
$60
Exact Sciences Corporation
$54
PFIZER INC.
$42
Bayer Healthcare Pharmaceuticals Inc.
$41
Next Science LLC
$29
Nevro Corp.
$29
Osiris Therapeutics Inc.
$25
Amarin Pharma Inc.
$25
Boston Scientific Corporation
$22
Novartis Pharmaceuticals Corporation
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
Teva Pharmaceuticals USA, Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11
Novum Pharma, LLC
$11
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 42.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · ANORO · APLENZIN · APLIGRAF · AREXVY · Alcortin A · Apligraf · CHANTIX · COLLAGENASE SANTYL · Cologuard Collection Kit · Diamondback Peripheral · Dojolvi · ENTRESTO · ETERNA · Exogen · GRAFIX/GRAFIXPL/STRAVIX · GRALISE · INVOKANA · JARDIANCE · Kerendia · LIVALO · LOREEV XR · LYRICA · MITRACLIP · MOUNJARO · Ozempic · Penta SCS Leads · Rybelsus · SEGLENTIS · Seglentis · Senza · SurgX · TRELEGY ELLIPTA · Vascepa · WELLBUTRIN · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a podiatrist in Pasadena?
Compare podiatrists in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse podiatrists nearby

Geographic Context

Podiatrists within 10 mi
258
Per 100K population
2.6
County median income
$87,760
Nearest hospital
AURORA LAS ENCINAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Avakian is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Avakian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Avakian performed 733 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Avakian receive payments from pharmaceutical companies?
Yes. Dr. Avakian received a total of $2,022 from 26 companies across 64 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Avakian's costs compare to other podiatrists in Pasadena?
Dr. Avakian's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Avakian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →